COMPANY PROFILE
BioNTech SE
SE (European Company)MainzManufacture of pharmaceutical preparations
REGISTERED SINCE
2008
18+ years registered
TRADE REGISTER
HRB 48720
Mainz
INDUSTRY
Manufacture of pharmaceutical preparations
SIZE CLASS
Large enterprise
Key questions answered
What does the company do?
Die Erforschung und Entwicklung, die Herstellung und die Vermarktung von immunologischen und von RNA-basierten Arzneimitteln und Testverfahren zur Diagnostik, Vorbeugung und Therapie von Krebserkrankungen, Infektionskrankheiten und anderen schwerwiegenden Krankheiten.
Original text from the German commercial register
Who leads it?
Annemarie Hanekamp, and 6 more
How large is it?
Large enterprise
How stable is it?
Stability assessment in the full profile
Business activity
Die BioNTech SE ist ein Biotechnologieunternehmen, das sich auf die Erforschung und Entwicklung von immunologischen und RNA-basierten Arzneimitteln fokussiert. Das Unternehmen bietet mRNA-Impfstoffe, innovative Immuntherapien, Antikörperkandidaten sowie diagnostische Testverfahren an, die zur Bekämpfung von Krebs und Infektionskrankheiten eingesetzt werden. Die Zielgruppe umfasst Patienten, medizinisches Fachpersonal sowie Forschungseinrichtungen, sowohl im B2C- als auch im B2B-Bereich, vorwiegend in der Biotechnologie und der pharmazeutischen Industrie. BioNTech zeichnet sich durch seine wissenschaftliche Präzision, Innovationskraft und umfangreiche Erfahrung in der Entwicklung von Immuntherapien aus und hat sich als Vorreiter im Bereich mRNA-Technologie etabliert.
Available in German only
Industry (WZ2008)
Manufacture of pharmaceutical preparations
WZ C21.20
Size class
Large
Industry (WZ2008) (3)
- C21.20Manufacture of pharmaceutical preparations
- M72.11Research and experimental development on biotechnology
- M72.19Other research and experimental development on natural sciences and engineering
Business purpose
Die Erforschung und Entwicklung, die Herstellung und die Vermarktung von immunologischen und von RNA-basierten Arzneimitteln und Testverfahren zur Diagnostik, Vorbeugung und Therapie von Krebserkrankungen, Infektionskrankheiten und anderen schwerwiegenden Krankheiten.
Original text from the German commercial register
Address & Contact
Legal essentials
- Register entry
- HRB 48720 (Mainz)
- Legal form
- SE (European Company)
- Registered since
- 08 Jun 2008
- Share capital
- €259,027,487
- Representation rules
- Available in the full profile
Annual statements
- Balance sheet
- €22.6bn
- Year
- 2024
16 annual statements are on file for this company.
Annual financial statements (PDF)
The most recently published annual financial statements as a PDF, straight from the German company register.
Included in the free account's starter credit, then 10 Implicents, only if found.
Sign up free and downloadSignals
Four dimensions from hard data — age, financials, register events, compliance. The ratings themselves are in the full profile.
- Continuity1Available in the full profile
- Financials2Available in the full profile
- Management3Available in the full profile
- Legal status4Available in the full profile
Directors & officers
Executive board
Annemarie Hanekamp
Board Member
Kylie Jimenez
Board Member
A further 9 registered persons are in the full profile.
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Companies with a similar profile
Location neighbours
BioNTech Real Estate Holding GmbH
Mainz · ⌂ same building
NT Security and Services GmbH
Mainz · ⌂ same building
BioNTech mRNA Services GmbH
Mainz · ⌂ same building
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server at mcp.implisense.com — usable with ChatGPT, Claude and your own agents.
Plus opens every profile
Every company profile in full, without spending Implicents on it — plus wider search reach, unlimited lists and the enriched export.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- The full commercial register history — on every profile
- Full search reach instead of the first page of hits
- Enriched Excel export (Plus only)